Literature DB >> 18657205

Differential expression of CD26 on virus-specific CD8(+) T cells during active, latent and resolved infection.

Chris C Ibegbu1, Yong-Xian Xu, Dimitri Fillos, Henry Radziewicz, Arash Grakoui, Athena P Kourtis.   

Abstract

The hallmark of effective establishment of immune memory is the long-term memory cell that persists in the absence of antigen. To explore its characteristics, we investigated the differences between a resolved successful immune response, such as after influenza (flu) vaccination, and the state of chronic infection with persistent antigen, such as with cytomegalovirus (CMV), Epstein-Barr virus (EBV) or human immunodeficiency virus (HIV), which leads to defective T-cell memory. Immunophenotypic analyses using multi-parameter flow cytometry and tetramer technology identified a unique pattern of CD26(high) expression among influenza-specific CD8(+) T cells, but not among CD8(+) T cells specific for CMV, EBV (three different epitopes) or HIV. The median percentage of CD8(+) T cells expressing CD26 was 95.5% for influenza, but for cells specific for CMV, EBV and HIV it was 10.5%, 12%-19%, and 13.2%, respectively. These findings suggest that expression of CD26(high) may be a characteristic of a memory cell. CD26(high) expression correlates with expression of CD127, a marker of memory cells. Furthermore, CD26(high) cells can produce interleukin-2. These findings offer insight into the dynamics of T-cell differentiation, and they may offer a specific marker of a successfully developed memory CD8(+) T cell, that of CD26(high). This marker has the potential to be useful in studies of immune responses to infectious agents, and to new vaccine candidates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18657205      PMCID: PMC2669815          DOI: 10.1111/j.1365-2567.2008.02899.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  Immediate early effector functions of virus-specific CD8+CCR7+ memory cells in humans defined by HLA and CC chemokine ligand 19 tetramers.

Authors:  Eugene V Ravkov; Christy M Myrick; John D Altman
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

Review 2.  Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue.

Authors:  Debbie van Baarle; Stefan Kostense; Marinus H J van Oers; Dorte Hamann; Frank Miedema
Journal:  Trends Immunol       Date:  2002-12       Impact factor: 16.687

Review 3.  Memory T cells and vaccines.

Authors:  Mark T Esser; Rocio D Marchese; Lisa S Kierstead; Lynda G Tussey; Fubao Wang; Narendra Chirmule; Michael W Washabaugh
Journal:  Vaccine       Date:  2003-01-17       Impact factor: 3.641

Review 4.  Immunological memory to viral infections.

Authors:  Raymond M Welsh; Liisa K Selin; Eva Szomolanyi-Tsuda
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

Review 5.  The role of programming in memory T-cell development.

Authors:  David Masopust; Susan M Kaech; E John Wherry; Rafi Ahmed
Journal:  Curr Opin Immunol       Date:  2004-04       Impact factor: 7.486

6.  Viral infections induce abundant numbers of senescent CD8 T cells.

Authors:  D Voehringer; C Blaser; P Brawand; D H Raulet; T Hanke; H Pircher
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

7.  Antigen burden is major determinant of human immunodeficiency virus-specific CD8+ T cell maturation state: potential implications for therapeutic immunization.

Authors:  Lynda G Tussey; Ushasree Sadasivan Nair; Margaret Bachinsky; Bradley H Edwards; Janna Bakari; Karen Grimm; Joseph Joyce; Rupert Vessey; Roy Steigbigel; Michael N Robertson; John W Shiver; Paul A Goepfert
Journal:  J Infect Dis       Date:  2003-01-24       Impact factor: 5.226

8.  Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infection.

Authors:  G Alter; G Hatzakis; C M Tsoukas; K Pelley; D Rouleau; R LeBlanc; J G Baril; H Dion; E Lefebvre; R Thomas; P Côté; N Lapointe; J P Routy; R P Sékaly; B Conway; N F Bernard
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

9.  Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.

Authors:  Susan M Kaech; Joyce T Tan; E John Wherry; Bogumila T Konieczny; Charles D Surh; Rafi Ahmed
Journal:  Nat Immunol       Date:  2003-11-16       Impact factor: 25.606

10.  Differential costimulation through CD137 (4-1BB) restores proliferation of human virus-specific "effector memory" (CD28(-) CD45RA(HI)) CD8(+) T cells.

Authors:  Edward C P Waller; Nicola McKinney; Ray Hicks; Andrew J Carmichael; J G Patrick Sissons; Mark R Wills
Journal:  Blood       Date:  2007-09-18       Impact factor: 22.113

View more
  19 in total

Review 1.  Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.

Authors:  C Klemann; L Wagner; M Stephan; S von Hörsten
Journal:  Clin Exp Immunol       Date:  2016-05-13       Impact factor: 4.330

2.  Altered proportions of naïve, central memory and terminally differentiated central memory subsets among CD4+ and CD8 + T cells expressing CD26 in patients with type 1 diabetes.

Authors:  Elena Matteucci; Massimo Ghimenti; Serena Di Beo; Ottavio Giampietro
Journal:  J Clin Immunol       Date:  2011-09-02       Impact factor: 8.317

3.  CD26-mediated co-stimulation in human CD8(+) T cells provokes effector function via pro-inflammatory cytokine production.

Authors:  Ryo Hatano; Kei Ohnuma; Junpei Yamamoto; Nam H Dang; Chikao Morimoto
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

4.  Deciphering the Plasmodium falciparum malaria-specific CD4+ T-cell response: ex vivo detection of high frequencies of PD-1+TIGIT+ EXP1-specific CD4+ T cells using a novel HLA-DR11-restricted MHC class II tetramer.

Authors:  Sophia Schulte; Janna Heide; Christin Ackermann; Sven Peine; Michael Ramharter; Maria Sophia Mackroth; Robin Woost; Thomas Jacobs; Julian Schulze Zur Wiesch
Journal:  Clin Exp Immunol       Date:  2022-04-04       Impact factor: 4.330

5.  High-throughput and high-dimensional single-cell analysis of antigen-specific CD8+ T cells.

Authors:  Ke-Yue Ma; Alexandra A Schonnesen; Chenfeng He; Amanda Y Xia; Eric Sun; Eunise Chen; Katherine R Sebastian; Yu-Wan Guo; Robert Balderas; Mrinalini Kulkarni-Date; Ning Jiang
Journal:  Nat Immunol       Date:  2021-11-22       Impact factor: 31.250

6.  Altered CD4+ T cell immunity in nurses occupationally exposed to viral pathogens.

Authors:  G Elias; A Souquette; S Heynderickx; I De Meester; H Jansens; P Beutels; P Van Damme; E Smits; P G Thomas; V Van Tendeloo; B Ogunjimi
Journal:  Clin Exp Immunol       Date:  2018-09-19       Impact factor: 4.330

7.  Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.

Authors:  Mary A Fletcher; Xiao R Zeng; Kevin Maher; Silvina Levis; Barry Hurwitz; Michael Antoni; Gordon Broderick; Nancy G Klimas
Journal:  PLoS One       Date:  2010-05-25       Impact factor: 3.240

8.  High-dimensional profiling clusters asthma severity by lymphoid and non-lymphoid status.

Authors:  Matthew J Camiolo; Xiaoying Zhou; Timothy B Oriss; Qi Yan; Michael Gorry; William Horne; John B Trudeau; Kathryn Scholl; Wei Chen; Jay K Kolls; Prabir Ray; Florian J Weisel; Nadine M Weisel; Nima Aghaeepour; Kari Nadeau; Sally E Wenzel; Anuradha Ray
Journal:  Cell Rep       Date:  2021-04-13       Impact factor: 9.423

9.  CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis.

Authors:  Oscar J Cordero; Rubén Varela-Calviño; Tania López-González; Cristina Calviño-Sampedro; Juan E Viñuela; Coral Mouriño; Íñigo Hernández-Rodríguez; Marina Rodríguez-López; Bruno Aspe de la Iglesia; José María Pego-Reigosa; José María Pego
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

10.  Effect of natalizumab on circulating CD4+ T-cells in multiple sclerosis.

Authors:  Lars Börnsen; Jeppe Romme Christensen; Rikke Ratzer; Annette Bang Oturai; Per Soelberg Sørensen; Helle Bach Søndergaard; Finn Sellebjerg
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.